# Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis

> **NCT06922331** · — · COMPLETED · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 21 (actual)

## Conditions studied

- Crohn's Disease (CD)
- Ulcerative Colitis (UC)
- Refractory Crohn's Disease
- Refractory Ulcerative Colitis
- Inflammatory Bowel Disease (IBD)
- Pediatric Crohn's Disease
- Geriatric Ulcerative Colitis

## Interventions

- **DRUG:** Upadacitinib

## Key facts

- **NCT ID:** NCT06922331
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922331, "Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06922331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*